Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six Weeks vs Six Months Valganciclovir in Congenital CMV
NCT00466817Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valganciclovir in congenital cytomegalovirus infection (cCMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2008; status: completed.
02
Drugs
valganciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on NCT00466817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466817.